Literature DB >> 30756129

UniCAP offers a long term treatment for middle-aged patients, who are not revised within the first 9 years.

Jens Ole Laursen1,2,3, Christian Backer Mogensen4,5, Helene Skjøt-Arkil4,5.   

Abstract

PURPOSE: The aim of this study was to investigate the long-term outcome of the unicompartmental knee resurfacing prosthesis (UniCAP) using clinical and radiographic assessments, and to evaluate the revision and survival rates.
METHODS: This was a prospective cohort study of patients with UniCAP prostheses with 6-9 years of follow-up. The clinical examination included the Knee Society Score (KSS) and Visual Analogue Scale (VAS) score. The radiographic examination included the Kellgren-Lawrence (KL) grading scale. A comparison analysis of the clinical preoperative and follow-up data and a Kaplan-Meier survival analysis were performed.
RESULTS: Of the 64 UniCAP patients, 36 (56%) were revised and one died. Examinations were performed on 23 (85%) of them. When compared with the preoperative data, the examinations showed a significant increase in the KSS objective [mean = 47.4, standard deviation (SD) = 5.8 vs. mean = 90.0, SD = 6.9] and function (mean = 46.7, SD = 6.8 vs. mean = 91.1, SD = 6.9) scores, a decrease in the VAS-score (mean = 7.3, SD = 0.5 vs. mean = 3.4, SD = 1.4) and a significant increase in the KL medial score (mean = 1.7, SD = 0.6 vs. mean = 2.1, SD = 0.5). The Kaplan-Meier survival rate after 5 years indicated good long-term outcomes.
CONCLUSIONS: There was a survival rate of approximately 40% after 9 years of follow-up, but in the group of patients (35-65 years old) not eligible for a final total arthroplasty. These patients were often left with pain and disability. This implant can be a temporary or even long-term treatment because it improved the disability and function over the long-term without a major progression in the osteoarthritis, function or pain. Long term results of this mini-prosthesis have not been previously reported. LEVEL OF EVIDENCE: IV.

Entities:  

Keywords:  Cartilage injury; Condylar implant; Early osteoarthritis; Femoral resurfacing; Knee prosthesis; Large cartilage lesions; Small implants

Mesh:

Year:  2019        PMID: 30756129     DOI: 10.1007/s00167-019-05356-y

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  5 in total

Review 1.  [Guidelines for the treatment of unicompartmental cartilage defects of the knee-Cartilage repair, osteotomy, mini-implant or arthroplasty?]

Authors:  Christoph Becher; Andreas Imhoff
Journal:  Orthopade       Date:  2020-12-18       Impact factor: 1.087

2.  A longterm prospective follow-up study of resurfacing miniprosthesis suitable for patients above sixtyfive years with localized cartilage lesions or early osteoarthritis in the knee.

Authors:  Jens Ole Laursen; Martin Lind; Christian Backer Mogensen; Helene Skjøt-Arkil
Journal:  J Exp Orthop       Date:  2020-12-06

Review 3.  A Systematic Review of Focal Cartilage Defect Treatments in Middle-Aged Versus Younger Patients.

Authors:  Ralph M Jeuken; Pieter P W van Hugten; Alex K Roth; Ufuk Tan Timur; Tim A E J Boymans; Lodewijk W van Rhijn; William D Bugbee; Pieter J Emans
Journal:  Orthop J Sports Med       Date:  2021-10-15

4.  Eighty Percent Survival of Resurfacing Implants in the Knee After 10 Years: A Nationwide Cohort Study on 379 Procedures from the Danish Knee Arthroplasty Registry.

Authors:  Bjørn B Christensen; Anders El-Galaly; Jens Ole Laursen; Martin Lind
Journal:  Cartilage       Date:  2021-07-14       Impact factor: 3.117

5.  Patient-specific metal implants for focal chondral and osteochondral lesions in the knee; excellent clinical results at 2 years.

Authors:  Johannes Holz; Tim Spalding; Tarek Boutefnouchet; Pieter Emans; Karl Eriksson; Mats Brittberg; Lars Konradsen; Clemens Kösters; Peter Verdonk; Magnus Högström; Martin Lind
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-10-06       Impact factor: 4.114

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.